BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31917795)

  • 1. Soluble AXL as a marker of disease progression and survival in melanoma.
    Flem-Karlsen K; Nyakas M; Farstad IN; McFadden E; Wernhoff P; Jacobsen KD; Flørenes VA; Mælandsmo GM
    PLoS One; 2020; 15(1):e0227187. PubMed ID: 31917795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden.
    Johansson G; Peng PC; Huang PY; Chien HF; Hua KT; Kuo ML; Chen CT; Lee MJ
    PLoS One; 2014; 9(12):e115916. PubMed ID: 25551830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.
    Reichl P; Fang M; Starlinger P; Staufer K; Nenutil R; Muller P; Greplova K; Valik D; Dooley S; Brostjan C; Gruenberger T; Shen J; Man K; Trauner M; Yu J; Gao CF; Mikulits W
    Int J Cancer; 2015 Jul; 137(2):385-394. PubMed ID: 25529751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
    Dengler M; Staufer K; Huber H; Stauber R; Bantel H; Weiss KH; Starlinger P; Pock H; Klöters-Plachky P; Gotthardt DN; Rauch P; Lackner C; Stift J; Brostjan C; Gruenberger T; Kumada T; Toyoda H; Tada T; Weiss TS; Trauner M; Mikulits W
    Oncotarget; 2017 Jul; 8(28):46234-46248. PubMed ID: 28526812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood.
    Ekman C; Stenhoff J; Dahlbäck B
    J Thromb Haemost; 2010 Apr; 8(4):838-44. PubMed ID: 20088931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
    Song X; Wu A; Ding Z; Liang S; Zhang C
    Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AXL receptor tyrosine kinase is increased in patients with heart failure.
    Batlle M; Recarte-Pelz P; Roig E; Castel MA; Cardona M; Farrero M; Ortiz JT; Campos B; Pulgarín MJ; Ramírez J; Pérez-Villa F; García de Frutos P
    Int J Cardiol; 2014 May; 173(3):402-9. PubMed ID: 24681018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axl is related to inflammation in hemodialysis patients.
    Li M; Xue W; Li X; Song Y; Liu X; Qin L
    Mol Immunol; 2021 May; 133():146-153. PubMed ID: 33667984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH.
    Grøndal SM; Tutusaus A; Boix L; Reig M; Blø M; Hodneland L; Gausdal G; Jackson A; Garcia de Frutos P; Lorens JB; Morales A; Marí M
    Front Immunol; 2024; 15():1400553. PubMed ID: 38817615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum.
    Budagian V; Bulanova E; Orinska Z; Duitman E; Brandt K; Ludwig A; Hartmann D; Lemke G; Saftig P; Bulfone-Paus S
    Mol Cell Biol; 2005 Nov; 25(21):9324-39. PubMed ID: 16227584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of Growth Arrest-Specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction.
    Caldentey G; García De Frutos P; Cristóbal H; Garabito M; Berruezo A; Bosch X; San Antonio R; Flores-Umanzor E; Perea RJ; De Caralt TM; Rodríguez J; Ortiz-Pérez JT
    Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):708-716. PubMed ID: 29119801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting the GAS6/AXL axis suppresses tumor progression by blocking the interaction between cancer-associated fibroblasts and cancer cells in gastric carcinoma.
    Bae CA; Ham IH; Oh HJ; Lee D; Woo J; Son SY; Yoon JH; Lorens JB; Brekken RA; Kim TM; Han SU; Park WS; Hur H
    Gastric Cancer; 2020 Sep; 23(5):824-836. PubMed ID: 32239298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression.
    von Mässenhausen A; Brägelmann J; Billig H; Thewes B; Queisser A; Vogel W; Kristiansen G; Schröck A; Bootz F; Brossart P; Kirfel J; Perner S
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28025482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia.
    Ekman C; Gottsäter A; Lindblad B; Dahlbäck B
    Clin Biochem; 2010 Jul; 43(10-11):873-6. PubMed ID: 20417630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis.
    Parodis I; Ding H; Zickert A; Cosson G; Fathima M; Grönwall C; Mohan C; Gunnarsson I
    PLoS One; 2019; 14(2):e0212068. PubMed ID: 30742665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes.
    Ekman C; Linder A; Akesson P; Dahlbäck B
    Crit Care; 2010; 14(4):R158. PubMed ID: 20731857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells.
    Vouri M; An Q; Birt M; Pilkington GJ; Hafizi S
    Oncotarget; 2015 Jun; 6(18):16183-97. PubMed ID: 25980499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble AXL is ubiquitously present in malignant serous effusions.
    Flem Karlsen K; McFadden E; Flørenes VA; Davidson B
    Gynecol Oncol; 2019 Feb; 152(2):408-415. PubMed ID: 30448261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum levels of soluble Axl in acute coronary syndrome.
    Liu YW; Yang QF; Zuo PY; Xiao CL; Chen XL; Liu CY
    Am J Med Sci; 2015 Feb; 349(2):124-9. PubMed ID: 25474223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.